X. Mirabel

5.4k total citations · 1 hit paper
167 papers, 3.4k citations indexed

About

X. Mirabel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, X. Mirabel has authored 167 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 66 papers in Surgery and 61 papers in Oncology. Recurrent topics in X. Mirabel's work include Advanced Radiotherapy Techniques (43 papers), Gastric Cancer Management and Outcomes (28 papers) and Esophageal Cancer Research and Treatment (23 papers). X. Mirabel is often cited by papers focused on Advanced Radiotherapy Techniques (43 papers), Gastric Cancer Management and Outcomes (28 papers) and Esophageal Cancer Research and Treatment (23 papers). X. Mirabel collaborates with scholars based in France, Spain and Hungary. X. Mirabel's co-authors include Éric Lartigau, T. Lacornerie, S. Dewas, Antoine Adenis, Jean‐Emmanuel Bibault, Éric François, Jean‐Pierre Gérard, C. Mariette, Thierry Conroy and Bernard Denis and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

X. Mirabel

158 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2

2010 537 citations Pierre-Luc Etienne, V. Vendrely et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
X. Mirabel	1.8k	1.4k	1.2k	666	527	167	3.4k
Christopher L. Hallemeier	2.0k 1.1×	1.5k 1.1×	1.4k 1.2×	318 0.5×	351 0.7×	143	3.5k
Anand Mahadevan	694 0.4×	2.1k 1.5×	1.4k 1.2×	698 1.0×	653 1.2×	117	3.5k
Satoshi Ishikura	2.1k 1.2×	3.3k 2.4×	993 0.8×	1.1k 1.6×	751 1.4×	157	4.6k
Falk Roeder	675 0.4×	1.5k 1.1×	992 0.8×	510 0.8×	403 0.8×	114	2.4k
Jong Hoon Kim	2.6k 1.4×	2.1k 1.5×	2.2k 1.8×	874 1.3×	932 1.8×	199	5.4k
Basil S. Hilaris	2.0k 1.1×	3.4k 2.4×	1.3k 1.1×	1.1k 1.6×	615 1.2×	151	5.5k
Nobukazu Fuwa	1.1k 0.6×	1.3k 1.0×	936 0.8×	450 0.7×	322 0.6×	183	2.7k
Revathy B. Iyer	1.5k 0.8×	768 0.5×	765 0.6×	324 0.5×	875 1.7×	108	4.0k
Víctor A. Marcial	1.8k 1.0×	1.3k 1.0×	1.4k 1.2×	461 0.7×	462 0.9×	102	4.2k
Gabriella Macchia	1.2k 0.7×	1.4k 1.0×	1.2k 1.0×	1.0k 1.5×	812 1.5×	318	3.6k

Countries citing papers authored by X. Mirabel

Since Specialization

Citations

This map shows the geographic impact of X. Mirabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Mirabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Mirabel more than expected).

Fields of papers citing papers by X. Mirabel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Mirabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Mirabel. The network helps show where X. Mirabel may publish in the future.

Co-authorship network of co-authors of X. Mirabel

This figure shows the co-authorship network connecting the top 25 collaborators of X. Mirabel. A scholar is included among the top collaborators of X. Mirabel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X. Mirabel. X. Mirabel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roos, Małgorzata, Marie‐Cécile Le Deley, Dominique Pasquier, et al.. (2024). Multicriteria optimization of radiation therapy: Towards empowerment and standardization of reverse planning for head and neck squamous cell carcinoma. Cancer/Radiothérapie. 28(4). 317–322.

Meyer, Nicolás, et al.. (2024). Sequential combination of sonic hedgehog inhibitors followed by consolidation radiotherapy in locally advanced basal cell carcinoma. Clinical and Experimental Dermatology. 49(9). 1024–1028. 3 indexed citations

Tourneau, C. Le, Zoltán Takácsi‐Nagy, Laetitia Finzi, et al.. (2023). Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). S99–S99. 1 indexed citations

Coutté, Alexandre, et al.. (2023). Radiothérapie du cancer du sein en cinq fractions. Cancer/Radiothérapie. 27(6-7). 531–534. 1 indexed citations

Adenis, Antoine, Guillaume Piessen, Samuel Le Sourd, et al.. (2023). Trimodality therapy with carboplatin/paclitaxel (CP) or FOLFOX (FFX) for esophageal/esogastric junctional cancer (EC/EGJ): Expanded safety and efficacy data from PROTECT.. Journal of Clinical Oncology. 41(4_suppl). 370–370.

Escande, Alexandre, et al.. (2023). An Effective Primary Treatment Using Radiotherapy in Patients with Eyelid Merkel Cell Carcinoma. Current Oncology. 30(7). 6353–6361. 2 indexed citations

Vendrely, V., Philippe Ronchin, Mathieu Minsat, et al.. (2023). Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial. Radiotherapy and Oncology. 186. 109742–109742. 4 indexed citations

Crop, F., et al.. (2022). Comparison of compressed sensing and controlled aliasing in parallel imaging acceleration for 3D magnetic resonance imaging for radiotherapy preparation. Physics and Imaging in Radiation Oncology. 23. 44–47. 3 indexed citations

Ninni, Sandro, Cédric Klein, Benjamin Longère, et al.. (2022). Stereotactic Radioablation for Ventricular Tachycardia in the Setting of Electrical Storm. Circulation Arrhythmia and Electrophysiology. 15(9). e010955–e010955. 38 indexed citations

10.

Bataille, B., Alexandre Escande, Fabrice Narducci, et al.. (2019). Intracavitary Preoperative Brachytherapy Followed By Whertheim-Type Hysterectomy in Localized Cervical Cancer: Clinical Data and Toxicity Results from a Single Institution Experience. International Journal of Radiation Oncology*Biology*Physics. 105(1). E319–E320. 2 indexed citations

11.

Faivre, Jean, D. Peiffert, V. Vendrely, et al.. (2018). Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03). Radiotherapy and Oncology. 129(3). 463–470. 13 indexed citations

12.

Gronnier, Caroline, Florence Renaud, Flora Hec, et al.. (2016). Esophageal adenocarcinoma: Impact of a large hiatal hernia on outcomes after surgery. Annals of Oncology. 27. vi223–vi223. 1 indexed citations

13.

Basset‐Séguin, Nicole, A. Dupuy, Philippe Saïag, et al.. (2016). VISMONEO - a phase II study assessing vismodegib in the neoadjuvant treatment of locally advanced basal cell carcinoma - Patients characteristics. Annals of Oncology. 27. vi399–vi399. 1 indexed citations

14.

Mirabel, X., et al.. (2015). Vismodegib induces significant clinical response in locally advanced trichoblastic carcinoma. British Journal of Dermatology. 173(4). 1059–1062. 18 indexed citations

15.

Lubrano, V., Stéphane Derrey, G. Truc, et al.. (2014). Traitements locorégionaux de métastase(s) cérébrale(s) chez des patients atteints d’un mélanome cutané métastatique : recommandations nationales françaises. Neurochirurgie. 60(6). 269–275. 1 indexed citations

16.

Fumagalli, I., Jean‐Emmanuel Bibault, S. Dewas, et al.. (2012). A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. Radiation Oncology. 7(1). 164–164. 38 indexed citations

17.

Penel, Nicolas, et al.. (2011). Radiotherapy alone for Merkel cell carcinoma: A comparative and retrospective study of 25 patients. Journal of the American Academy of Dermatology. 65(5). 983–990. 47 indexed citations

18.

Dupuis, Olivier, G. Ganem, G. Béra, et al.. (2010). Cancer de l’œsophage. Cancer/Radiothérapie. 14. S74–S83. 5 indexed citations

19.

Penel, Nicolas, M O Vilain, L. Vanseymortier, et al.. (2003). Fréquence des génopathies et des antécédents carcinologiques chez 493 adultes atteints de sarcomes viscéraux ou des tissus mous. Bulletin du Cancer. 90(10). 887–895. 10 indexed citations

20.

Delaporte, Éric, et al.. (2003). Complications cutanées de la radiothérapie (hors tumeurs malignes). Bulletin du Cancer. 90(4). 319–325. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact